Dr. Alaa Ali, MD

Dr. Ali practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Ali's NPI, 1841546876, was assigned on July 27, 2012. Dr. Ali holds District of Columbia license MD049363.

Dr. Ali's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Ali's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dr. Ali is also affiliated with MedStar Georgetown University Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Ali to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ali practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Ali's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Ali is licensed in District of Columbia.

CMS data shows 437 Medicare services from Dr. Ali across 6 procedure codes in 2024, for 78 Medicare patients. Medicare paid $41,732 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 78 Medicare patients who saw Dr. Ali in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ali's median patient age at 63, with 50% women.

In 2024, Dr. Ali wrote 88 Medicare Part D claims for 17 patients. 92% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $1,148 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Ali for performance year 2024. Dr. Ali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 80 papers to Dr. Ali, published from 2011 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Immunotherapy, Adoptive, Leukemia, Myeloid, Acute and Receptors, Chimeric Antigen. Dr. Ali has published most often in BMJ Case Rep. Dr. Ali's most frequent co-authors are Aibek Mirrakhimov, MD, Raya Saba, MD and John F. Dipersio, MD.

CMS Open Payments shows 37 general payments to Dr. Ali from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. Kite Pharma, Inc. paid the most, $13,055.